Bispecific Drugs for Cancers
Exhibitor: Center for Biomedical Research and Development
Booth No: N416
Characteristic
The existing drugs for glioblastoma and pancreatic cancer cannot effectively improve the overall survival rate of patients. We have successfully developed bispecific drugs targeting integrins and VEGFR2 pathways that can significantly reduce tumor growth and increase the survival rate. Our animal analyses showed that they are effective protein drugs for the treatments of glioblastoma and pancreatic cancer.
Other Products
-
Antithrombotic Drug with Low Risk of Bleeding
-
Fibrin and Platelet-targeting Thrombolytic Drug
-
Anti-fibrotic Drug Targeting ECM
-
Modification Platforms for Protein Therapeutics
-
Protein Production and GLP Laboratory
Highest Rated Products
-
Pneumatic Liquid Filling Machine
-
Powder Machine-High Speed Mixer / Granulator
-
Planetary Vacuum Mixer
-
SEMI-AUTOMATIC EYESHADOW PRESS MACHINE
-
2ton Mixing and Melting Tank with Storage Tanks
-
High Speed Mixing Machine
-
In-Line Homogenizer
-
VACUUM EMULSIFY MIXING EQUIPMENT (Bottom Homogenized Series)
-
VACUUM EMULSIFY MIXING EQUIPMENT
-
VACUUM EMULSIFY MIXING EQUIPMENT
-
SuitNifty Scar Gel (Non-Sterile)
-
Natural Marine Collagen
-
TISUCODETM Type II Collagen Capsules
-
Feelife Foaming Wash
-
HUO-FU Collagen Probiotics
-
Feelife Collagen Repair Cream
-
Feelife Intensive Revitalizing Mask
-
Collagen Freeze Crystal Set
-
Life Fusion Collagen Wound Dressing
-
Absorbable Collagen Membrane
-
Lysozyme Hydrochloride
-
Betamethasone Valerate
-
Tadalafil
-
effervescent tablet
-
Etofenamate
-
Hyoscine Butylbromide
-
Betamethasone Sodium Phosphate
-
Carbimazole
-
Betamethasone Dipropionate
-
Ginkgo Dry Extract, Refined and Quantified
